ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DRIO DarioHealth Corporation

1.42
-0.04 (-2.74%)
01 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
DarioHealth Corporation NASDAQ:DRIO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.04 -2.74% 1.42 1.42 1.63 1.53 1.45 1.47 19,857 01:00:00

DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH

21/03/2024 12:30pm

PR Newswire (US)


DarioHealth (NASDAQ:DRIO)
Historical Stock Chart


From Mar 2024 to Jun 2024

Click Here for more DarioHealth Charts.

Company to host conference call and webcast at 8:30am ET

NEW YORK, March 21, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 4th quarter ended December 31, 2023, on Thursday, March 28th, 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time.

DarioHealth Corp. Logo

Erez Raphael, Chief Executive Officer and Rick Anderson, President, will host the call.

Conference Call Details

Date: Thursday, March 28th, 8:30am ET

Dial-in Number: 1-888-886-7786 (domestic) or 1-416-764-8658 (international)

Call me™: https://emportal.ink/3T9QM65

Participants can use the dial-in numbers above and be answered by an operator OR click the Call me™ link for instant telephone access to the event. This link will be made active 15 minutes prior to scheduled start time.

Webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1659828&tp_key=33195a8703

Participants are asked to dial in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through Sunday, April 28th, 2024. To listen to the replay, dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and use replay passcode 63790103.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. 

Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results.  Making the right thing to do the easy thing to do.

Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers.  To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.

DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280

DarioHealth Investor Relations Contact
Kat Parella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922

Media Contact:
Scott Stachowiak
Scott.Stachowiak@russopartnersllc.com
+1-646-942-5630

 

Logo - https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg

 

Cision View original content:https://www.prnewswire.com/news-releases/dariohealth-to-report-fourth-quarter-2023-results-on-thursday-march-28th-302095878.html

SOURCE DarioHealth Corp.

Copyright 2024 PR Newswire

1 Year DarioHealth Chart

1 Year DarioHealth Chart

1 Month DarioHealth Chart

1 Month DarioHealth Chart